Is herpes simplex virus (HSV) contagious?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Herpes Simplex Contagious?

Yes, herpes simplex virus (HSV) is highly contagious and transmits primarily through direct contact with infected oral secretions, skin lesions, or genital fluids during both symptomatic outbreaks and asymptomatic periods when no visible lesions are present. 1

Primary Transmission Mechanisms

Direct Contact Transmission

  • HSV spreads through direct mucosal or skin contact with infected sites, including oral-to-oral, oral-to-genital, and genital-to-genital contact. 1, 2
  • The virus requires access to mucosal surfaces or microabrasions in the epithelium to establish infection. 3
  • Vesicles formed during outbreaks contain thousands of infectious viral particles, creating the highest transmission risk when visible lesions are present. 3

Asymptomatic Transmission: The Critical Pitfall

  • Most genital herpes transmission occurs during asymptomatic viral shedding when no visible lesions are present—this is the primary mode of HSV-2 spread. 4, 3
  • Approximately 87% of HSV-2-infected individuals are unaware they have the infection, leading to inadvertent transmission during asymptomatic periods. 3
  • Only 9% of HSV-2-seropositive persons report knowing they have genital herpes, meaning the vast majority transmit unknowingly. 1
  • Asymptomatic viral shedding occurs more frequently in patients with HSV-2 compared to HSV-1 genital infection, and in those infected for less than 12 months. 3

Transmission Risk by Type and Route

HSV-2 (Genital Herpes)

  • Genital herpes transmits predominantly through sexual contact with infected genital fluids or mucosal surfaces. 1
  • In prospective couple studies, the overall transmission risk is approximately 10-14% per year when one partner has symptomatic genital HSV and the other is initially seronegative. 5, 6
  • Transmission risk appears significantly higher from males to females than females to males. 5
  • Women who are both HSV-1 and HSV-2 seronegative face higher transmission risk (23%) compared to those with pre-existing HSV-1 antibodies (6%). 5

HSV-1 (Oral and Genital)

  • HSV-1 is becoming an increasingly common cause of first-episode genital herpes, particularly through oral-genital contact. 3
  • Approximately 47.8% of the US population aged 14-49 years is seropositive for HSV-1. 3
  • While HSV-1 can cause genital infection, clinical recurrences are much less frequent than with HSV-2 genital infection. 4

High-Risk Transmission Scenarios

During Symptomatic Outbreaks

  • Transmission risk peaks during visible genital lesions or ulcers when viral loads are markedly higher. 3
  • Sexual contact should be avoided when visible lesions or prodromal symptoms (tingling, burning, pain) are present. 3, 1

Perinatal Transmission

  • The highest neonatal transmission risk (30-50%) occurs when women have primary HSV infection during delivery. 1
  • Transmission risk is much lower (0-5%) for infants born to women with reactivated infection. 1
  • Prolonged rupture of membranes (>6 hours) increases HSV transmission risk to infants. 1

Healthcare Settings

  • HSV can be transmitted through droplets and direct contact, requiring appropriate infection control measures. 7
  • Healthcare workers can develop herpetic whitlow through contact with infected lesions without glove protection. 7

Contagious Period Characteristics

Primary Infection

  • The initial HSV-2 infection in a previously seronegative individual is associated with the highest viral loads and longest duration of viral shedding, making this the most contagious phase. 3
  • The incubation period ranges from 2-10 days (up to 4 weeks), during which asymptomatic viral shedding and transmission can occur. 3

Recurrent Infections

  • Reactivation episodes vary from once every several years to multiple times per month, with each episode creating transmission opportunities. 3
  • Frequent asymptomatic shedding and unrecognized symptomatic cases are the primary sources of continued HSV-2 transmission. 1

Impact on HIV Transmission

  • HSV-2 infection increases HIV acquisition risk approximately 3-fold, likely due to genital tract inflammation and enhanced viral entry points. 3, 1
  • Approximately 70% of HIV-infected persons are HSV-2 seropositive. 1
  • Women infected with HIV, particularly those with low CD4+ counts, shed HSV from vulva and cervix more commonly than HIV-uninfected women, with most shedding being asymptomatic. 1

Common Misconceptions to Avoid

  • Do not assume that avoiding sex only during visible outbreaks prevents transmission—the majority of transmission occurs during asymptomatic periods. 4, 3
  • HSV is not transmitted by casual contact; direct mucosal or skin contact with infected sites is required. 4, 1
  • Post-exposure antiviral prophylaxis is NOT indicated for preventing initial HSV infection, even when contact occurred 24 hours before lesion appearance. 1

References

Guideline

Transmission and Prevention of Herpes Simplex Virus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Reducing HSV-2 Transmission Without Condoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.